163 related articles for article (PubMed ID: 8222289)
1. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis.
Shi Y; Zou M; Farid NR
Clin Endocrinol (Oxf); 1993 Sep; 39(3):269-74. PubMed ID: 8222289
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
[TBL] [Abstract][Full Text] [Related]
3. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
4. Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation.
Brabant G; Maenhaut C; Köhrle J; Scheumann G; Dralle H; Hoang-Vu C; Hesch RD; von zur Mühlen A; Vassart G; Dumont JE
Mol Cell Endocrinol; 1991 Nov; 82(1):R7-12. PubMed ID: 1761161
[TBL] [Abstract][Full Text] [Related]
5. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.
Elisei R; Pinchera A; Romei C; Gryczynska M; Pohl V; Maenhaut C; Fugazzola L; Pacini F
J Clin Endocrinol Metab; 1994 Apr; 78(4):867-71. PubMed ID: 8157713
[TBL] [Abstract][Full Text] [Related]
6. High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.
Puppin C; Fabbro D; Dima M; Di Loreto C; Puxeddu E; Filetti S; Russo D; Damante G
J Endocrinol; 2008 May; 197(2):401-8. PubMed ID: 18434370
[TBL] [Abstract][Full Text] [Related]
7. TSH-receptor expression and human thyroid disease: relation to clinical, endocrine, and molecular thyroid parameters.
Schuppert F; Deiters S; Rambusch E; Sierralta W; Dralle H; von zur Muhlen A
Thyroid; 1996 Dec; 6(6):575-87. PubMed ID: 9001192
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues.
Hoang-Vu C; Dralle H; Scheumann G; Maenhaut C; Horn R; von zur Mühlen A; Brabant G
Exp Clin Endocrinol; 1992; 100(1-2):51-6. PubMed ID: 1281780
[TBL] [Abstract][Full Text] [Related]
9. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
Zou M; Shi Y; al-Sedairy S; Farid NR
Br J Cancer; 1993 Aug; 68(2):385-8. PubMed ID: 8394105
[TBL] [Abstract][Full Text] [Related]
10. Thyrotrophin receptor expression: does it help in assessing the prognosis of thyroid cancer?
Sheppard MC
Clin Endocrinol (Oxf); 1993 Sep; 39(3):267-8. PubMed ID: 8222288
[No Abstract] [Full Text] [Related]
11. The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues.
Ohta K; Endo T; Onaya T
Biochem Biophys Res Commun; 1991 Feb; 174(3):1148-53. PubMed ID: 1996981
[TBL] [Abstract][Full Text] [Related]
12. Changes of expression level of the differentiation markers in papillary thyroid carcinoma under thyrotropin suppression therapy in vivo immunohistochemical detection of thyroglobulin, thyroid peroxidase, and thyrotropin receptor.
Tanaka K; Sonoo H; Yamamoto Y; Udagawa K; Kunisue H; Arime I; Yamamoto S; Kurebayashi J; Shimozuma K
J Surg Oncol; 2000 Oct; 75(2):108-16. PubMed ID: 11064390
[TBL] [Abstract][Full Text] [Related]
13. c-Kit proto-oncogene is more likely to lose expression in differentiated thyroid carcinoma than three thyroid-specific genes: thyroid peroxidase, thyroglobulin, and thyroid stimulating hormone receptor.
Tanaka T; Umeki K; Yamamoto I; Kotani T; Sakamoto F; Noguchi S; Ohtaki S
Endocr J; 1995 Oct; 42(5):723-8. PubMed ID: 8574299
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
[TBL] [Abstract][Full Text] [Related]
15. Induction of c-fos and c-myc mRNA expression by immunoglobulin G from patients with Graves' disease in thyrotrophin-dependent rat thyroid cell line (FRTL5).
Hatabu H; Kasagi K; Iida Y; Nosaka T; Misaki T; Hidaka A; Tokuda Y; Endo K; Mori T; Lee K
Clin Endocrinol (Oxf); 1991 May; 34(5):349-56. PubMed ID: 1905596
[TBL] [Abstract][Full Text] [Related]
16. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
17. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue.
Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G
J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952
[TBL] [Abstract][Full Text] [Related]
18. Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.
Tanaka K; Inoue H; Miki H; Masuda E; Kitaichi M; Komaki K; Uyama T; Monden Y
Br J Cancer; 1997; 76(5):594-9. PubMed ID: 9303357
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
Int J Cancer; 1993 Aug; 55(1):37-43. PubMed ID: 8102129
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels.
Khosla S; Oursler MJ; Schroeder MJ; Eberhardt NL
Endocrinology; 1994 Nov; 135(5):1887-93. PubMed ID: 7956909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]